Skip to content

Clinical trials

Shock, Cardiogenic trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Status: Unknown status Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20161
20181
20191
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital3
Nanjing Medical University2
First Affiliated Hospital Xi'an Jiaotong University1
Fujian Medical University1
Renmin Hospital of Wuhan University1
Second Affiliated Hospital of Guangzhou Medical University1
Shenzhen Core Medical Technology CO.,LTD.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic10
Heart Arrest3
Heart Failure2
Acute Coronary Syndrome1
Cardiac Output, Low1
Coronary Artery Disease1
Myocardial Infarction1
Respiratory Distress Syndrome1
Shock, Septic1
Ventricular Dysfunction, Left1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.